PROK · Prokidney Corp. · Executive Compensation
$1.41
-0.02 (-1.40%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plan, we do not believe our existing cash and cash equivalents and marketable securities as of June 30, 2026, will be sufficient to fund our obligations for the 12 months following the issuance of the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q on August 10, 2026. Accordingly, substantial doubt exists about our ability to continue as a going concern within one year after the date the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$426.27M
Shares
302.32M
Volume · Oct 23
535.23K
Avg daily vol (3M)
1.3M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Bruce Culleton | Chief Executive Officer | $2,956,447 |
| Todd C. Girolamo | Chief Legal Officer | $1,367,562 |
| James Coulston | Chief Financial Officer | $1,367,332 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Todd C. Girolamo | Chief Legal Officer | $1,260,899 |
| Bruce Culleton | Chief Executive Officer | $1,015,802 |
| James Coulston | Chief Financial Officer | $950,127 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Bruce Culleton | Chief Executive Officer | $8,712,140 |
| Tim Bertram | Former Chief Executive Officer | $7,575,176 |
| Deepak Jain | Former Chief Operating Officer | $4,525,183 |
| Todd C. Girolamo | Chief Legal Officer | $2,295,042 |
| James Coulston | Chief Financial Officer | $2,286,608 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Tim Bertram | Former Chief Executive Officer | $46,133,565 |
| Deepak Jain | Former Chief Operating Officer | $12,759,825 |
| Todd C. Girolamo | Chief Legal Officer | $8,238,116 |
| Bruce Culleton | Chief Executive Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Tim Bertram | Chief Executive Officer | $873,761 |
| Deepak Jain | Chief Operating Officer | $632,216 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lucio Tozzi | Senior Vice President of Global Clinical Operations | Appointed | 2024-03-25 |
| Ulrich Ernst, Ph.D. | Executive Vice President, Technical Operations | Appointed | 2024-03-25 |
| Deepak Jain, Ph.D. | Chief Operating Officer | Terminated | 2023-11-30 |
| Bruce Culleton | Chief Executive Officer | Appointed | 2023-11-13 |
| Bruce Culleton | Class III director | Appointed | 2023-11-13 |
| Tim Bertram | Chief Executive Officer | Terminated | 2023-11-13 |
| Jennifer Fox | member of the board of directors | Appointed | 2022-07-15 |
| Uma Sinha | Class III director | Appointed | 2022-07-12 |
| Pablo Legorreta | Chairperson of the ProKidney Corp. board of directors | Appointed | 2022-07-12 |
| Tim Bertram | Class III director | Appointed | 2022-07-12 |
| Pablo Legorreta | Class III director | Appointed | 2022-07-12 |
| John M. Maraganore | Class II director | Appointed | 2022-07-12 |
| José Ignacio Jiménez Santos | Class II director | Appointed | 2022-07-12 |
| Brian J.G. Pereira | Class I director | Appointed | 2022-07-12 |
| Alan M. Lotvin | Class I director | Appointed | 2022-07-12 |
| William F. Doyle | Class I director | Appointed | 2022-07-12 |
Leadership
- Bruce Culleton CEO, Board Member
- Bruce Culleton, MD CEO, Board Member
- Pablo Legorreta Chairman, Board Member
- James Coulston CFO
- Alan M. Lotvin Board Member
- Brian J.G. Pereira Board Member
- Jennifer Fox Board Member
- José Ignacio Jiménez Santos Board Member
- Marc Semigran Board Member
- Tim Bertram Board Member
- Uma Sinha Board Member
- William F. Doyle Board Member
Key facts
CIK
1850270
CUSIP
74291D104
13F (30d)
12 filings
12 filers
Visit website
Investor relations